Skip to content

Enhancing Children's Cognitive Function and Achievement Through Carotenoid Consumption

Enhancing Children's Cognitive Function and Achievement Through Carotenoid Consumption

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05177679
Enrollment
113
Registered
2022-01-04
Start date
2022-06-23
Completion date
2026-07-12
Last updated
2026-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Achievement, Cognitive Change, Macular Pigmentation

Keywords

Lutein, Zeaxanthin, Carotenoids, Child, Spatial memory, Hippocampus, Academic success, Cognition

Brief summary

The aim of this study is to test the casual relationship between carotenoid supplementation, cognitive function, and achievement over a school-year. The central hypothesis is that, relative to the waitlist placebo group, children receiving the carotenoid supplement will exhibit greater gains in cognitive function and achievement.

Detailed description

This clinical trial will be a randomized placebo-controlled double-blind trial to examine the effects of carotenoid supplementation on cognitive control, hippocampal-dependent relational memory, and academic achievement among pre-adolescents over one school year (i.e. 9-months).

Interventions

DIETARY_SUPPLEMENTActive supplement

Carotenoid supplement comprised of 10mg lutein and 2mg zeaxanthin.

DIETARY_SUPPLEMENTPlacebo control

Placebo control supplement

Sponsors

University of Illinois at Urbana-Champaign
Lead SponsorOTHER
Northeastern University
CollaboratorOTHER
University of Georgia
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

Randomized, placebo-controlled, double-blind trial.

Eligibility

Sex/Gender
ALL
Age
8 Years to 10 Years
Healthy volunteers
Yes

Inclusion criteria

* Child assent and parent/guardian consent * 8-10 years of age * No lutein supplementation within 6-months prior to enrollment (exception of multivitamins containing less than 1 mg lutein/day) * Absence of learning disability (parent-reported) * Tanner scale score ≤ 2 * 20/20 or corrected vision

Exclusion criteria

* Non-assent of child or non-consent of guardian * Above/below 8-10 years of age * Lutein supplementation within 6-months prior to enrollment (including multivitamins containing more than 1 mg lutein/day) * Identified learning disability (parent-reported) * Tanner scale score \> 2 * Not 20/20 or uncorrected vision

Design outcomes

Primary

MeasureTime frameDescription
Attentional Accuracy9 months (Baseline vs Follow-up)Changes in accuracy (%) between groups using a computerized flanker task.
Attentional Reaction Time9 months (Baseline vs Follow-up)Changes in reaction time (ms) between groups using a computerized flanker task.
Hippocampal-dependent Relational memory9 months (Baseline vs Follow-up)Spatial memory task accuracy
Composite Academic Achievement9 months (Baseline vs Follow-up)Kaufman Test of Academic and Educational Achievement II (KTEA III) composite or comprehensive academic achievement score. The scores are standard scores with a minimum score of 40 and a maximum score of 160 where a higher score indicates a better outcome.

Secondary

MeasureTime frameDescription
Macular Pigment Optical Density9 months (Baseline vs Follow-up)Changes in Macular Pigment Optical Density (log units) between groups using a macular densitometer.
Attentional Resource Allocation9 months (Baseline vs Follow-up)Changes in P3 event related potential amplitude (microvolts) between groups using a computerized flanker task.
Attentional Processing Speed9 months (Baseline vs Follow-up)Changes in P3 event related potential latency (ms) between groups using a computerized flanker task.
Math9 months (Baseline vs Follow-up)Assessed as Mass subtest standard scores on the KTEA III. The scores are standard scores with a minimum score of 40 and a maximum score of 160 where a higher score indicates a better outcome.
Reading9 months (Baseline vs Follow-up)Assessed as Reading subtest standard scores on the KTEA III. The scores are standard scores with a minimum score of 40 and a maximum score of 160 where a higher score indicates a better outcome.
Written Language9 months (Baseline vs Follow-up)Assessed as Written Language subtest standard scores on the KTEA III. The scores are standard scores with a minimum score of 40 and a maximum score of 160 where a higher score indicates a better outcome.
Reading Fluency9 months (Baseline vs Follow-up)Assessed as Reading Fluency subtest standard scores on the KTEA III. The scores are standard scores with a minimum score of 40 and a maximum score of 160 where a higher score indicates a better outcome.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORNaiman Khan, PhD

University of Illinois Urbana-Champaign

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 28, 2026